A collaboration between Karolinska Institutet, Karolinska University Hospital, and SciLifeLab has integrated whole genome sequencing into routine diagnostic investigations for rare diseases at ...
Caelan and his family manage to raise hundreds of pounds for Kidney Research UK.
Since its launch, CNBC has rolled out a weekly CNBC Cures newsletter, a podcast, a live event, and has featured several TV ...
A newly developed AI tool can dramatically speed up the search for the genetic causes of rare diseases, a process that often ...
A recent case study found a possible new trigger for a dangerous, and sometimes fatal, virus that could be laying dormant in ...
Founded on the pillars of policy, research, education and advocacy, this new institute within the College of Science aims to ...
When David Fajgenbaum and his colleagues launched the drug repurposing non-profit Every Cure, they chose a path that ...
MedPage Today on MSN
FDA Signals Regulatory Flexibility With Accelerated Approval of Rare Disease Drug
Tividenofusp alfa is the first approved treatment for neurologic complications of Hunter s ...
Avlayah is the first Hunter syndrome therapy approved to address the condition’s neurologic complications, according to Tracy ...
Critical Path Institute (C-Path) today announced the launch of One to Millions, a global, multi-stakeholder public-private ...
The FDA has approved Denali Therapeutics’ enzyme replacement therapy for a genetic lysosomal storage disease after a string ...
Upon approval, Rocket has been awarded a priority review voucher, which currently fetch around $200m on the secondary market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results